Impact Factor
3.13
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.37
403 total citations
h5-index
23
h5 depth signal
Cited share
64.0%
112 of 175
Total citations
403
Citation footprint
Metric signal
2.02
External metric anchor
Self-citation
3.2%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
491
China
127
Turkey
66
Japan
55
South Korea
53
Citing Fields of Research
Ophthalmology
827
Drug Delivery Systems
80
Pharmacology & Toxicology
26
Cell Biology
25
Antibiotic & Antibacterial Agents
19
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,057
Articles tracked across the journal lifetime
Indexed publication set
175
112 cited publications
Last 12 months
115
9.6 publications/month
Open access share
7.0%
8 OA publications in the last year
Leading citing country
United States
491 citing publications
Leading citing field
Ophthalmology
827 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v11n1, 1995-
v11n1, 1995-
Active Coverage
Research Focus & Classification
Indexed Subjects
Ophthalmology
Issuing & Sponsoring Bodies
Contributor
Association for Ocular Pharmacology and Therapeutics
Broad Categories
Drug Therapy
Ophthalmology
Pharmacology
MeSH Descriptors
Eye Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/10807683261497924
Open DOI
Topical Tacrolimus in Ocular Disease: A Narrative Review of Mechanism of Action and Therapeutic Applications
Purpose: Immune-mediated inflammatory disorders of the ocular surface and anterior segment frequently require sustained immunosuppression, yet prolonged topical corticosteroid use carries the risk of glaucoma, cataract, and infection. Ta...
02
DOI 10.1177/10807683261496831
Open DOI
Ocular Distribution and Metabolite Profiling of Vorolanib in Rats and Its In Vitro Metabolism Using Human Recombinant Enzymes
Purpose: Vorolanib is a multitarget tyrosine kinase inhibitor with anti-angiogenic potential for diabetic macular edema (DME) and neovascular age-related macular degeneration (wAMD), but its ocular disposition and metabolism are unclear....
03
DOI 10.1177/10807683261496779
Open DOI
Innovative Iteration of Anti-Inflammatory Therapies and Delivery Technologies for Dry Eye: A Multidimensional Perspective
Purpose: To investigate the effect of anti-inflammatory drug classes, delivery methods, and personalized regimens on ocular surface health in dry eye patients, providing evidence-based support for optimizing medication regimens. Method: ...
04
DOI 10.1177/10807683261497216
Open DOI
The FAST Study: Examining Quality of Vision Outcomes in Dry Eye Disease Patients with Severe Keratitis Treated with the Ciclosporin A Cationic Emulsion
Purpose: Examination of the relationship between improvements in dry eye disease (DED) signs and changes in functional visual acuity (FVA) parameters with ciclosporin A 0.1% cationic emulsion (CsA 0.1% CE) treatment. Methods: Adults with...
05
DOI 10.1177/10807683261491684
Open DOI
Eyes on New Product Development—Number 136
06
DOI 10.1177/10807683261486972
Open DOI
mTOR/Autophagy//NF-κB Axis Drives Benzalkonium Chloride-Induced Inflammatory Response in Corneal Epithelial Cells
Purpose: Benzalkonium chloride (BAK), a quaternary ammonium antimicrobial agent widely utilized in ophthalmic formulations, is associated with chronic ocular surface toxicity. BAK induces corneal epithelial inflammation and autophagic im...
07
DOI 10.1177/10807683261484815
Open DOI
Real-World Dosing Intervals for Long-Acting Anti-VEGF Intravitreal Injection Therapies in nAMD and DME: Academy IRIS ® Registry Analysis
Purpose: To determine real-world dosing intervals for long-acting intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapies in patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema ...
08
DOI 10.1177/10807683261485625
Open DOI
Carbon Dots as Versatile Nanoplatforms for Ophthalmic Therapeutics
Carbon dots (CDs), an emerging class of carbon-based nanomaterials, have attracted increasing interest in ophthalmology owing to their excellent biocompatibility, unique optical properties, tunable surface chemistry, and superior tissue ...
09
DOI 10.1177/10807683261475800
Open DOI
Management of Neuropathic Ocular Pain Associated with Dry Eye Disease in a 5-Year Prospective Cohort
Purpose: This study aimed to assess the long-term management and 5-year evolution of patients with neuropathic ocular pain (NOP) associated with chronic dry eye disease (DED). Methods: Fourteen patients with NOP underwent a 5-year follow...
10
DOI 10.1177/10807683261480480
Open DOI
Cytoprotective Potential of N -Acetylcysteine in an In Vitro Model of Retinal Oxidative Injury
Purpose: Sodium iodate (NaIO 3 ) is a well-established oxidizing agent that induces oxidative stress (OS) in ARPE-19 cells, while antioxidants such as N -acetylcysteine (NAC) have demonstrated cytoprotective effects in retinal degenerati...
Bibliographical & Catalog Notes
Title from cover.